The two components of the ERK1/2 complex are always found to be co-localized in colorectal carcinomas [17], [18], [19], [20], and the ERK1 and ERK2 MAPKs have attracted intense research interest because of their critical involvement in the regulation of cell proliferation and surviva [17]. This evidence concerns the gene MAPK3 and colorectal carcinoma.